Stock To Watch: Alnylam Pharmaceuticals, Inc. (ALNY)
- The stock finished Q1 2023 at $200.32.
- RBC has given the stock a Price Target of $275.
- RBC projects that the stock will rise by 37.3% in the next 12 months.
- The company is not currently profitable.
- It has a 52-week range of $117.58 - $242.97.